AbbVie | ABBV - Stock


AbbVie reported $5.13B in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Abbott USD 6.99B 501M Mar/2026
ALKERMES USD 298.96M 37.75M Jun/2026
Amgen USD 6.22B 34M Jun/2026
AstraZeneca USD 6.93B 362M Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Eisai JPY 257.55B 21.09B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
J&J USD 15.14B 561M Jun/2026
Medtronic USD 6.31B 153M Dec/2025
Merck USD 6.48B 179M Mar/2026
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
United Therapeutics USD 193.8M 15.5M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026
Zoetis USD 2.57B 24M Jun/2026